Adi Cohen is an Endocrinology/Metabolic physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 131 publications with 4,646 citations (h-index 38); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Romosozumab/Denosumab Study for Premenopausal IOP
Sponsor: Columbia University
- Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP
Sponsor: Elizabeth Shane
- Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Sponsor: Elizabeth Shane
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
52.2%Parathyroid Hormone Analog29.9%Teriparatide100%Part D<11 patientsl-Thyroxine22.4%Levothyroxine Sodium100%Part D<11 patientsMusculoskeletal
47.8%Bisphosphonates28.4%Risedronate Sodium100%Part D<11 patientsRANK Ligand Inhibitor19.4%Prolia100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2007–2021 per NIH RePORTER. The latest:
- Pregnancy and lactation associated osteoporosis: Bone microstructure and metabolism, genotypic characteristics, natural history and biomarkers of disease severity
Columbia University Health Sciences
FY2021$393,866R01FD006007 - Pregnancy and lactation associated osteoporosis: Bone microstructure and metabolism, genotypic characteristics, natural history and biomarkers of disease severity
Columbia University Health Sciences
FY2020$387,210R01FD006007 - Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Phase 2 Study
Columbia University Health Sciences
FY2019$499,998R01FD003902
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Fahn, MD
Columbia University Irving Medical Center
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”